The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PKA, based on extensive structural and biochemical characterization, has emerged as a prototypical model for the entire kinome (3).”
From A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit (2026) · cites this paper as [3]
In the citing paper
“Down-regulation of PKA-C activity slows the progression of polycystic kidney disease (3, 24, 25)”
From A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit (2026) · cites this paper as [3]
In the citing paper
“as both hypo- or hyper-phosphorylation of downstream substrates may lead to signalopathies [7].”
From Allosteric binding cooperativity in kinases signaling, signalopathies, and drug development (2025) · cites this paper as [7]
In the citing paper
“cAMP-dependent protein kinase A (PKA) is a prototypical kinase that phosphorylates hundreds of substrates and plays a critical role in numerous signal transduction pathways [7].”
From Allosteric binding cooperativity in kinases signaling, signalopathies, and drug development (2025) · cites this paper as [7]
In the citing paper
“Recent efforts in genomic medicine have revealed a series of mutations and gene fusions associated with diseases such as the Carney complex, Cushing’s syndrome, myxomas, and fibrolamellar hepatocellular carcinomas [99, 100].”
From An NMR portrait of functional and dysfunctional allosteric cooperativity in cAMP‐dependent protein kinase A (2023) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
COSMIC: the Catalogue Of Somatic Mutations In Cancer
Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.
Seamon, K. B., Padgett, W., & Daly, J. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3363 · Cited by 1,658
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
AKAP signalling complexes: focal points in space and time
Wong, W., & Scott, J. D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1527 · Cited by 1,073
ClinVar: improvements to accessing data
Landrum, M. J., Chitipiralla, S., Brown, G. R., Chen, C., Gu, B., Hart, J., Hoffman, D., Jang, W., Kaur, K., Liu, C., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz972 · Cited by 994
Rothwell, P. M., Wilson, M., Price, J. F., Belch, J. F., Meade, T. W., & Mehta, Z. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60209-8 · Cited by 984
Research works printed but not linked: 392
- Acin-Perez, 2009, Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation, Cell Metab, 9, 265, 10.1016/j.cmet.2009.01.012 · DOI · Paper page
- Adams, 1995, Phosphorylation modulates catalytic function and regulation in the cAMP-dependent protein kinase, Biochemistry, 34, 2447, 10.1021/bi00008a007 · DOI
- Alakus, 2014, Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin, Genome Med, 6, 43, 10.1186/gm559 · DOI
- Alberini, 1994, C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia, Cell, 76, 1099, 10.1016/0092-8674(94)90386-7 · DOI · Paper page
- Ali, 2015, Updated global burden of cholera in endemic countries, PLoS Negl Trop Dis, 9, 10.1371/journal.pntd.0003832 · DOI · Paper page
- Almeida, 2012, Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations, J Clin Endocrinol Metab, 97, E687, 10.1210/jc.2011-3000 · DOI
- Almeida, 2010, Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling, Hum Mol Genet, 19, 1387, 10.1093/hmg/ddq014 · DOI
- Altarejos, 2011, CREB and the CRTC co-activators: sensors for hormonal and metabolic signals, Nat Rev Mol Cell Biol, 12, 141, 10.1038/nrm3072 · DOI · Paper page
- Amarante, 2018, Potential use of CXCL12/CXCR4 and sonic hedgehog pathways as therapeutic targets in medulloblastoma, Acta Oncol, 57, 1134, 10.1080/0284186X.2018.1473635 · DOI
- Amato, 2014, Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas, J Pathol, 233, 217, 10.1002/path.4344 · DOI · Paper page
- Amieux, 2002, The essential role of RI alpha in the maintenance of regulated PKA activity, Ann N Y Acad Sci, 968, 75, 10.1111/j.1749-6632.2002.tb04328.x · DOI · Paper page
- Ang, 2018, Genomic landscape of appendiceal neoplasms, JCO Precis Oncol, 2, 1, 10.1200/PO.17.00302 · DOI
- Angers, 2009, Proximal events in Wnt signal transduction, Nat Rev Mol Cell Biol, 10, 468, 10.1038/nrm2717 · DOI · Paper page
- Arang, 2020, G protein-coupled receptors and heterotrimeric G proteins as cancer drivers, FEBS Lett, 594, 4201, 10.1002/1873-3468.14017 · DOI
- Arveseth, 2021, Smoothened transduces Hedgehog signals via activity-dependent sequestration of PKA catalytic subunits, PLoS Biol, 19, 10.1371/journal.pbio.3001191 · DOI
- Asare, 2016, The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base, Cancer, 122, 213, 10.1002/cncr.29744 · DOI · Paper page
- Ashworth, 2018, Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?, Nat Rev Clin Oncol, 15, 564, 10.1038/s41571-018-0055-6 · DOI · Paper page
- Bachmann, 2016, Gpr161 anchoring of PKA consolidates GPCR and cAMP signaling, Proc Natl Acad Sci USA, 113, 7786, 10.1073/pnas.1608061113 · DOI · Paper page
- Bacskai, 1993, Spatially resolved dynamics of cAMP and protein kinase A subunits in Aplysia sensory neurons, Science, 260, 222, 10.1126/science.7682336 · DOI · Paper page
- Barzi, 2010, Sonic-hedgehog-mediated proliferation requires the localization of PKA to the cilium base, J Cell Sci, 123, 62, 10.1242/jcs.060020 · DOI
- Bates, 2006, Characterization of Gpr101 expression and G-protein coupling selectivity, Brain Res, 1087, 1, 10.1016/j.brainres.2006.02.123 · DOI
- Bathon, 2019, Alterations in protein kinase a substrate specificity as a potential cause of cushing syndrome, Endocrinology, 160, 447, 10.1210/en.2018-00775 · DOI · Paper page
- Bender, 2006, Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use, Pharmacol Rev, 58, 488, 10.1124/pr.58.3.5 · DOI · Paper page
- Bendzunas, 2018, Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2, Bioorg Med Chem, 26, 1174, 10.1016/j.bmc.2018.02.001 · doi:10.1016/j.bmc.2018.02.001
- Bentin Toaldo, 2015, Protein kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13, BMC Cancer, 15, 588, 10.1186/s12885-015-1591-4 · doi:10.1186/s12885-015-1591-4
- Berman, 2005, The cAMP binding domain: an ancient signaling module, Proc Natl Acad Sci USA, 102, 45, 10.1073/pnas.0408579102 · DOI · Paper page
- Bertherat, 2009, Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes, J Clin Endocrinol Metab, 94, 2085, 10.1210/jc.2008-2333 · DOI · Paper page
- Bertinetti, 2009, Chemical tools selectively target components of the PKA system, BMC Chem Biol, 9, 3, 10.1186/1472-6769-9-3 · DOI
- Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome, N Engl J Med, 370, 1019, 10.1056/NEJMoa1310359 · DOI · Paper page
- Bharati, 2011, Cholera toxin: a paradigm of a multifunctional protein, Indian J Med Res, 133, 179
- Bi, 2017, Clinical identification of oncogenic drivers and copy-number alterations in pituitary tumors, Endocrinology, 158, 2284, 10.1210/en.2016-1967 · DOI
- Bian, 2007, Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival, Neurosurgery, 61, 570, 10.1227/01.NEU.0000290905.53685.A2 · DOI
- Bianco, 1998, Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells, J Clin Invest, 101, 1737, 10.1172/JCI2361 · DOI · Paper page
- Biel, 2009, Cyclic nucleotide-regulated cation channels, J Biol Chem, 284, 9017, 10.1074/jbc.R800075200 · doi:10.1074/jbc.r800075200
- Bitterman, 2013, Pharmacological distinction between soluble and transmembrane adenylyl cyclases, J Pharmacol Exp Ther, 347, 589, 10.1124/jpet.113.208496 · DOI
- Blair, 2019, Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes, Biochem Soc Trans, 47, 1405, 10.1042/BST20190252 · DOI
- Bock, 2020, Optical mapping of cAMP signaling at the nanometer scale, Cell, 182, 1519, 10.1016/j.cell.2020.07.035 · DOI · Paper page
- Boikos, 2007, Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis, Hum Mol Genet, 16, R80, 10.1093/hmg/ddm019 · DOI
- Boora, 2015, Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines, Cancer Genet, 208, 374, 10.1016/j.cancergen.2015.04.002 · DOI
- Boswell-Smith, 2006, Phosphodiesterase inhibitors, Br J Pharmacol, 147, S252
- Bradley, 2005, Regulation of cyclic nucleotide-gated channels, Curr Opin Neurobiol, 15, 343, 10.1016/j.conb.2005.05.014 · DOI
- Bramson, 1984, Mechanistic studies of cAMP-dependent protein kinase action, CRC Crit Rev Biochem, 15, 93, 10.3109/10409238409102298 · DOI
- Brasaemle, 2009, Perilipin A and the control of triacylglycerol metabolism, Mol Cell Biochem, 326, 15, 10.1007/s11010-008-9998-8 · DOI · Paper page
- Brockmann, 2017, Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling, Nature, 546, 307, 10.1038/nature22376 · DOI · Paper page
- Brogna, 2009, Nonsense-mediated mRNA decay (NMD) mechanisms, Nat Struct Mol Biol, 16, 107, 10.1038/nsmb.1550 · DOI · Paper page
- Brown, 2005, COX-2: a molecular target for colorectal cancer prevention, J Clin Oncol, 23, 2840, 10.1200/JCO.2005.09.051 · DOI · Paper page
- Brown, 2006, The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness, Curr Pharm Des, 12, 3597, 10.2174/138161206778522100 · DOI
- Brown, 2013, Implementing fluorescence anisotropy screening and crystallographic analysis to define PKA isoform-selective activation by cAMP analogs, ACS Chem Biol, 8, 2164, 10.1021/cb400247t · DOI
- Brunelli, 1976, Synaptic facilitation and behavioral sensitization in Aplysia: possible role of serotonin and cyclic AMP, Science, 194, 1178, 10.1126/science.186870 · DOI · Paper page
- Bruystens, 2016, Structure of a PKA RIα recurrent acrodysostosis mutant explains defective cAMP-dependent activation, J Mol Biol, 428, 4890, 10.1016/j.jmb.2016.10.033 · DOI · Paper page
- Buckman, 1998, COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer, Carcinogenesis, 19, 723, 10.1093/carcin/19.5.723 · DOI · Paper page
- Bucko, 2020, Drugs that regulate local cell signaling: AKAP targeting as a therapeutic option, Annu Rev Pharmacol Toxicol, 61, 361, 10.1146/annurev-pharmtox-022420-112134 · DOI
- Bucko, 2019, Subcellular drug targeting illuminates local kinase action, eLife, 8, 10.7554/eLife.52220 · DOI
- Calatozzolo, 2006, Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas, Cancer Biol Ther, 5, 827, 10.4161/cbt.5.7.2838 · doi:10.4161/cbt.5.7.2838
- Calebiro, 2014, PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit, Nat Commun, 5, 5680, 10.1038/ncomms6680 · DOI · Paper page
- Calejo, 2015, Targeting protein-protein interactions in complexes organized by A kinase anchoring proteins, Front Pharmacol, 6, 192, 10.3389/fphar.2015.00192 · DOI
- Campbell, 2018, Targeting G protein-coupled receptor signalling by blocking G proteins, Nat Rev Drug Discov, 17, 789, 10.1038/nrd.2018.135 · DOI · Paper page
- Cannaerts, 2015, TGF-β signalopathies as a paradigm for translational medicine, Eur J Med Genet, 58, 695, 10.1016/j.ejmg.2015.10.010 · DOI
- Cao, 2019, Structures of the PKA RIα holoenzyme with the FLHCC driver J-PKAcα or wild-type PKAcα, Structure, 27, 816, 10.1016/j.str.2019.03.001 · doi:10.1016/j.str.2019.03.001
- Carballo, 2018, A highlight on Sonic hedgehog pathway, Cell Commun Signal, 16, 11, 10.1186/s12964-018-0220-7 · DOI · Paper page
- Carney, 1985, Differences between nonfamilial and familial cardiac myxoma, Am J Surg Pathol, 9, 53, 10.1097/00000478-198501000-00009 · doi:10.1097/00000478-198501000-00009
- Carr, 1992, Localization of the cAMP-dependent protein kinase to the postsynaptic densities by A-kinase anchoring proteins. Characterization of AKAP 79, J Biol Chem, 267, 16816, 10.1016/S0021-9258(18)41856-X · DOI · Paper page
- Castellone, 2005, Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis, Science, 310, 1504, 10.1126/science.1116221 · DOI · Paper page
- Castellucci, 1980, Intracellular injection of the catalytic subunit of cyclic AMP-dependent protein kinase simulates facilitation of transmitter release underlying behavioral sensitization in Aplysia, Proc Natl Acad Sci USA, 77, 7492, 10.1073/pnas.77.12.7492 · DOI · Paper page
- Chan, 2005, Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer, JAMA, 294, 914, 10.1001/jama.294.8.914 · DOI · Paper page
- Chang, 2007, Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology, J Biol Chem, 282, 21583, 10.1074/jbc.C700083200 · DOI · Paper page
- Chen, 2007, Mutation of an A-kinase-anchoring protein causes long-QT syndrome, Proc Natl Acad Sci USA, 104, 20990, 10.1073/pnas.0710527105 · DOI · Paper page
- Cheng, 1985, An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase, Biochem J, 231, 655, 10.1042/bj2310655 · DOI
- Chepurny, 2013, Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag, Mol Endocrinol, 27, 1267, 10.1210/me.2013-1029 · DOI
- Cheung, 2015, Structural insights into mis-regulation of protein kinase A in human tumors, Proc Natl Acad Sci USA, 112, 1374, 10.1073/pnas.1424206112 · DOI · Paper page
- Chijiwa, 1990, J Biol Chem, 265, 5267, 10.1016/S0021-9258(19)34116-X · DOI · Paper page
- Chin, 2017, Current insights into the role of PKA phosphorylation in CFTR channel activity and the pharmacological rescue of cystic fibrosis disease-causing mutants, Cell Mol Life Sci, 74, 57, 10.1007/s00018-016-2388-6 · DOI
- Christensen, 2003, cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension, J Biol Chem, 278, 35394, 10.1074/jbc.M302179200 · DOI · Paper page
- Colao, 2014, Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations, Pituitary, 17, 180, 10.1007/s11102-013-0483-3 · DOI
- Coles, 2020, Unbiased proteomic profiling uncovers a targetable GNAS/PKA/PP2A axis in small cell lung cancer stem cells, Cancer Cell, 38, 129, 10.1016/j.ccell.2020.05.003 · DOI
- Cook, 1993, Inhibition by cAMP of Ras-dependent activation of Raf, Science, 262, 1069, 10.1126/science.7694367 · DOI · Paper page
- Cornella, 2015, Unique genomic profile of fibrolamellar hepatocellular carcinoma, Gastroenterology, 148, 806, 10.1053/j.gastro.2014.12.028 · DOI
- Correa, 2015, Carney complex: an update, Eur J Endocrinol, 173, M85, 10.1530/EJE-15-0209 · DOI · Paper page
- Dagda, 2015, Role of protein kinase A in regulating mitochondrial function and neuronal development: implications to neurodegenerative diseases, Rev Neurosci, 26, 359, 10.1515/revneuro-2014-0085 · DOI
- Dash, 1990, Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation, Nature, 345, 718, 10.1038/345718a0 · DOI · Paper page
- De Leo, 2016, Hyperthyroidism, Lancet, 388, 906, 10.1016/S0140-6736(16)00278-6 · DOI · Paper page
- De Venanzi, 2014, Primary bilateral macronodular adrenal hyperplasia, Curr Opin Endocrinol Diabetes Obes, 21, 177, 10.1097/MED.0000000000000061 · DOI · Paper page
- Deeble, 2007, Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells, Cancer Res, 67, 3663, 10.1158/0008-5472.CAN-06-2616 · DOI
- Dema, 2016, The A-kinase anchoring protein (AKAP) glycogen synthase kinase 3β interaction protein (GSKIP) regulates β-catenin through its interactions with both protein kinase A (PKA) and GSK3β, J Biol Chem, 291, 19618, 10.1074/jbc.M116.738047 · DOI
- DeNinno, 2012, Future directions in phosphodiesterase drug discovery, Bioorg Med Chem Lett, 22, 6794, 10.1016/j.bmcl.2012.09.028 · DOI
- Dhillon, 2002, Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259, Mol Cell Biol, 22, 3237, 10.1128/MCB.22.10.3237-3246.2002 · DOI · Paper page
- Di Benedetto, 2018, Shaping mitochondrial dynamics: the role of cAMP signalling, Biochem Biophys Res Commun, 500, 65, 10.1016/j.bbrc.2017.05.041 · DOI
- Di Vito, 2015, The mysterious pathways of cardiac myxomas: a review of histogenesis, pathogenesis and pathology, Histopathology, 66, 321, 10.1111/his.12531 · DOI
- Dilly, 2017, Targeting G-protein coupled receptor-related signaling pathway in a murine xenograft model of appendiceal pseudomyxoma peritonei, Oncotarget, 8, 106888, 10.18632/oncotarget.22455 · DOI
- Drew, 2016, Aspirin and colorectal cancer: the promise of precision chemoprevention, Nat Rev Cancer, 16, 173, 10.1038/nrc.2016.4 · DOI · Paper page
- Dumaz, 2006, In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling, Cancer Res, 66, 9483, 10.1158/0008-5472.CAN-05-4227 · DOI · Paper page
- Durick, 1996, Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain, J Biol Chem, 271, 12691, 10.1074/jbc.271.22.12691 · doi:10.1074/jbc.271.22.12691
- Durick, 1995, Tyrosines outside the kinase core and dimerization are required for the mitogenic activity of RET/ptc2, J Biol Chem, 270, 24642, 10.1074/jbc.270.42.24642 · DOI
- Dyson, 2009, The differential regulation of steroidogenic acute regulatory protein-mediated steroidogenesis by type I and type II PKA in MA-10 cells, Mol Cell Endocrinol, 300, 94, 10.1016/j.mce.2008.11.029 · DOI
- Eichholtz, 1993, A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor, J Biol Chem, 268, 1982, 10.1016/S0021-9258(18)53951-X · DOI
- Engh, 1996, Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity, J Biol Chem, 271, 26157, 10.1074/jbc.271.42.26157 · DOI · Paper page
- Enkvist, 2006, Conjugation of adenosine and hexa-(D-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases, J Med Chem, 49, 7150, 10.1021/jm0605942 · doi:10.1021/jm0605942
- Enkvist, 2007, Carbocyclic 3′-deoxyadenosine-based highly potent bisubstrate-analog inhibitor of basophilic protein kinases, Bioorg Med Chem Lett, 17, 5336, 10.1016/j.bmcl.2007.08.016 · doi:10.1016/j.bmcl.2007.08.016
- Erion, 2009, Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein, Cell Metab, 10, 499, 10.1016/j.cmet.2009.10.007 · DOI
- Espiard, 2018, Activating PRKACB somatic mutation in cortisol-producing adenomas, JCI Insight, 3, 10.1172/jci.insight.98296 · DOI
- Fang, 2000, Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A, Proc Natl Acad Sci USA, 97, 11960, 10.1073/pnas.220413597 · DOI · Paper page
- Farquhar, 2008, Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity, J Virol, 82, 8797, 10.1128/JVI.00592-08 · DOI
- Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I · DOI · Paper page
- Feller, 2009, The nature of fibrous dysplasia, Head Face Med, 5, 22, 10.1186/1746-160X-5-22 · doi:10.1186/1746-160x-5-22
- Forlino, 2014, PRKACB and Carney complex, N Engl J Med, 370, 1065, 10.1056/NEJMc1309730 · DOI
- Fragoso, 2003, Cushing’s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene, J Clin Endocrinol Metab, 88, 2147, 10.1210/jc.2002-021362 · DOI · Paper page
- Freda, 2002, Somatostatin analogs in acromegaly, J Clin Endocrinol Metab, 87, 3013, 10.1210/jcem.87.7.8665 · doi:10.1210/jcem.87.7.8665 · Paper page
- Freda, 2007, Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission, Pituitary, 10, 275, 10.1007/s11102-007-0058-2 · doi:10.1007/s11102-007-0058-2
- Gadelha, 2017, The genetic background of acromegaly, Pituitary, 20, 10, 10.1007/s11102-017-0789-7 · DOI
- Gao, 2020, PROTAC technology: opportunities and challenges, ACS Med Chem Lett, 11, 237, 10.1021/acsmedchemlett.9b00597 · DOI · Paper page
- Giardiello, 1993, Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis, N Engl J Med, 328, 1313, 10.1056/NEJM199305063281805 · DOI · Paper page
- Gjertsen, 1995, Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action, J Biol Chem, 270, 20599, 10.1074/jbc.270.35.20599 · DOI · Paper page
- Gloerich, 2010, Epac: defining a new mechanism for cAMP action, Annu Rev Pharmacol Toxicol, 50, 355, 10.1146/annurev.pharmtox.010909.105714 · DOI · Paper page
- Goel, 2006, A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers, Invest New Drugs, 24, 125, 10.1007/s10637-006-2378-x · DOI
- Goessling, 2009, Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration, Cell, 136, 1136, 10.1016/j.cell.2009.01.015 · DOI · Paper page
- Goh, 2014, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors [published correction appears in Nat Genet (2014) 46:759], Nat Genet, 46, 613, 10.1038/ng.2956 · DOI · Paper page
- Gold, 2013, Engineering A-kinase anchoring protein (AKAP)-selective regulatory subunits of protein kinase A (PKA) through structure-based phage selection, J Biol Chem, 288, 17111, 10.1074/jbc.M112.447326 · DOI
- Graham, 2018, Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion, Hepatology, 68, 1441, 10.1002/hep.29719 · DOI
- Greene, 2008, In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay, Hum Mutat, 29, 633, 10.1002/humu.20688 · DOI
- Greenwald, 2011, Bigger, better, faster: principles and models of AKAP anchoring protein signaling, J Cardiovasc Pharmacol, 58, 462, 10.1097/FJC.0b013e31822001e3 · DOI
- Greggio, 2017, Cross-talk between LRRK2 and PKA: implication for Parkinson’s disease?, Biochem Soc Trans, 45, 261, 10.1042/BST20160396 · DOI
- Gu, 2009, Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines, Clin Cancer Res, 15, 7196, 10.1158/1078-0432.CCR-09-0585 · DOI
- Hage, 2018, Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas, J Clin Endocrinol Metab, 103, 1929, 10.1210/jc.2017-02287 · DOI
- Halls, 2017, Adenylyl cyclase signalling complexes - Pharmacological challenges and opportunities, Pharmacol Ther, 172, 171, 10.1016/j.pharmthera.2017.01.001 · DOI
- Ham, 1997, GH3 cells expressing constitutively active Gs alpha (Q227L) show enhanced hormone secretion and proliferation, Mol Cell Endocrinol, 127, 41, 10.1016/S0303-7207(96)03987-1 · doi:10.1016/s0303-7207(96)03987-1
- Hamada, 2017, Aspirin use and colorectal cancer survival according to tumor CD274 (programmed cell death 1 ligand 1) expression status, J Clin Oncol, 35, 1836, 10.1200/JCO.2016.70.7547 · DOI
- Hammarsjö, 2021, High diagnostic yield in skeletal ciliopathies using massively parallel genome sequencing, structural variant screening and RNA analyses, J Hum Genet, 10.1038/s10038-021-00925-x · DOI
- Hamuro, 2004, Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS), J Mol Biol, 340, 1185, 10.1016/j.jmb.2004.05.042 · DOI
- Hanke, 2011, Cyclic nucleotides as affinity tools: phosphorothioate cAMP analogues address specific PKA subproteomes, N Biotechnol, 28, 294, 10.1016/j.nbt.2010.12.001 · doi:10.1016/j.nbt.2010.12.001
- Hanks, 1995, Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification, FASEB J, 9, 576, 10.1096/fasebj.9.8.7768349 · DOI · Paper page
- Hannah-Shmouni, 2016, Genetics of gigantism and acromegaly, Growth Horm IGF Res, 30-31, 37, 10.1016/j.ghir.2016.08.002 · doi:10.1016/j.ghir.2016.08.002
- Hanoune, 2001, Regulation and role of adenylyl cyclase isoforms, Annu Rev Pharmacol Toxicol, 41, 145, 10.1146/annurev.pharmtox.41.1.145 · DOI · Paper page
- Hansen-Petrik, 2002, Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice, Cancer Res, 62, 403
- Hata, 2004, Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation, Pharmacol Ther, 103, 147, 10.1016/j.pharmthera.2004.06.003 · DOI · Paper page
- He, 2017, Recurrent somatic mutations of PRKAR1A in isolated cardiac myxoma, Oncotarget, 8, 103968, 10.18632/oncotarget.21916 · DOI
- He, 2014, The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma, Nat Med, 20, 1035, 10.1038/nm.3666 · DOI
- Hébrant, 2011, Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations, Eur J Endocrinol, 164, 1, 10.1530/EJE-10-0775 · DOI
- Herberg, 1993, Physiological inhibitors of the catalytic subunit of cAMP-dependent protein kinase: effect of MgATP on protein-protein interactions, Biochemistry, 32, 14015, 10.1021/bi00213a035 · DOI
- Herberg, 1999, Dissection of the nucleotide and metal−phosphate binding sites in cAMP-dependent protein kinase, Biochemistry, 38, 6352, 10.1021/bi982672w · DOI · Paper page
- Herberg, 2000, Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding, J Mol Biol, 298, 329, 10.1006/jmbi.2000.3662 · DOI · Paper page
- Hida, 1998, Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas, Cancer Res, 58, 3761
- Hidaka, 1984, Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C, Biochemistry, 23, 5036, 10.1021/bi00316a032 · DOI · Paper page
- Hino, 2005, Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination, Mol Cell Biol, 25, 9063, 10.1128/MCB.25.20.9063-9072.2005 · DOI · Paper page
- Hiroi, 1998, Human ACTH hypersensitivity syndrome associated with abnormalities of the ACTH receptor gene, Clin Endocrinol (Oxf), 48, 129, 10.1046/j.1365-2265.1998.3971187.x · DOI
- Hollingsworth, 2004, Mucins in cancer: protection and control of the cell surface, Nat Rev Cancer, 4, 45, 10.1038/nrc1251 · DOI · Paper page
- Holz, 2008, Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors, Cell Signal, 20, 10, 10.1016/j.cellsig.2007.07.009 · DOI
- Honeyman, 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
- Horvath, 2010, Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update, Hum Mutat, 31, 369, 10.1002/humu.21178 · DOI · Paper page
- Horvath, 2008, Large deletions of the PRKAR1A gene in Carney complex, Clin Cancer Res, 14, 388, 10.1158/1078-0432.CCR-07-1155 · DOI
- Houslay, 2003, PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization, Biochem J, 370, 1, 10.1042/bj20021698 · DOI · Paper page
- Howe, 2004, Regulation of actin-based cell migration by cAMP/PKA, Biochim Biophys Acta, 1692, 159, 10.1016/j.bbamcr.2004.03.005 · DOI · Paper page
- Hsiao, 2009, Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors, J Clin Endocrinol Metab, 94, 2930, 10.1210/jc.2009-0516 · DOI · Paper page
- Hu, 2018, Disease-causing mutations in the G Protein Galphas subvert the roles of GDP and GTP, Cell, 173, 1254, 10.1016/j.cell.2018.03.018 · DOI
- Huang, 1999, NH2-Terminal targeting motifs direct dual specificity A-kinase-anchoring protein 1 (D-AKAP1) to either mitochondria or endoplasmic reticulum, J Cell Biol, 145, 951, 10.1083/jcb.145.5.951 · DOI · Paper page
- Huang, 2002, Protein kinase A deficiency causes axially localized neural tube defects in mice, J Biol Chem, 277, 19889, 10.1074/jbc.M111412200 · DOI
- Huh, 2014, Novel nonsense GNAS mutation in a 14-month-old boy with plate-like osteoma cutis and medulloblastoma, J Dermatol, 41, 319, 10.1111/1346-8138.12284 · DOI
- Iacovazzo, 2016, Gigantism: X-linked acrogigantism and GPR101 mutations, Growth Horm IGF Res, 30-31, 64, 10.1016/j.ghir.2016.09.007 · DOI
- Ideno, 2013, Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype, Ann Surg, 258, 141, 10.1097/SLA.0b013e31828cd008 · DOI
- Iglesias-Bartolome, 2015, Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis, Nat Cell Biol, 17, 793, 10.1038/ncb3164 · DOI
- Impey, 2004, Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions, Cell, 119, 1041
- Innamorati, 2018, The curious case of Gαs gain-of-function in neoplasia, BMC Cancer, 18, 293, 10.1186/s12885-018-4133-z · DOI
- Javaid, 2019, Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium, Orphanet J Rare Dis, 14, 139, 10.1186/s13023-019-1102-9 · DOI · Paper page
- Jeong, 2013, cAMP signalling decreases p300 protein levels by promoting its ubiquitin/proteasome dependent degradation via Epac and p38 MAPK in lung cancer cells, FEBS Lett, 587, 1373, 10.1016/j.febslet.2013.03.010 · doi:10.1016/j.febslet.2013.03.010
- Jho, 2018, Dual role of YAP: oncoprotein and tumor suppressor, J Thorac Dis, 10, S3895, 10.21037/jtd.2018.10.70 · DOI
- Johnson, 2001, Dynamics of cAMP-dependent protein kinase, Chem Rev, 101, 2243, 10.1021/cr000226k · DOI · Paper page
- Julius, 2012, Signaling by sensory receptors, Cold Spring Harb Perspect Biol, 4, a005991, 10.1101/cshperspect.a005991 · DOI
- Kaelin, 2005, The concept of synthetic lethality in the context of anticancer therapy, Nat Rev Cancer, 5, 689, 10.1038/nrc1691 · DOI · Paper page
- Kajiyama, 2014, Extremely poor postrecurrence oncological outcome for patients with recurrent mucinous ovarian cancer, Int J Clin Oncol, 19, 121, 10.1007/s10147-013-0522-0 · doi:10.1007/s10147-013-0522-0
- Kamilaris, 2019, Carney Complex, Exp Clin Endocrinol Diabetes, 127, 156, 10.1055/a-0753-4943 · DOI
- Kan, 2010, Diverse somatic mutation patterns and pathway alterations in human cancers, Nature, 466, 869, 10.1038/nature09208 · DOI · Paper page
- Kandel, 2012, The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB, Mol Brain, 5, 14, 10.1186/1756-6606-5-14 · DOI · Paper page
- Kaper, 1995, Cholera, Clin Microbiol Rev, 8, 48, 10.1128/CMR.8.1.48 · DOI · Paper page
- Kase, 1987, K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases, Biochem Biophys Res Commun, 142, 436, 10.1016/0006-291X(87)90293-2 · DOI · Paper page
- Kastenhuber, 2017, DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma, Proc Natl Acad Sci USA, 114, 13076, 10.1073/pnas.1716483114 · DOI · Paper page
- Kaur, 2013, Mucins in pancreatic cancer and its microenvironment, Nat Rev Gastroenterol Hepatol, 10, 607, 10.1038/nrgastro.2013.120 · DOI · Paper page
- Kawamori, 2003, Enhancement of colon carcinogenesis by prostaglandin E2 administration, Carcinogenesis, 24, 985, 10.1093/carcin/bgg033 · DOI · Paper page
- Kee, 1996, Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator, J Biol Chem, 271, 2373, 10.1074/jbc.271.5.2373 · DOI · Paper page
- Kemp, 1977, Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase, J Biol Chem, 252, 4888, 10.1016/S0021-9258(17)40137-2 · DOI · Paper page
- Kennedy, 2015, Selective disruption of the AKAP signaling complexes, Methods Mol Biol, 1294, 137, 10.1007/978-1-4939-2537-7_11 · DOI
- Khan, 2018, Induced GnasR201H expression from the endogenous Gnas locus causes fibrous dysplasia by up-regulating Wnt/β-catenin signaling, Proc Natl Acad Sci USA, 115, E418, 10.1073/pnas.1714313114 · DOI
- Kijima, 2016, Molecular classification of medulloblastoma, Neurol Med Chir (Tokyo), 56, 687, 10.2176/nmc.ra.2016-0016 · DOI
- Kim, 2007, PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation, Cell, 130, 1032, 10.1016/j.cell.2007.07.018 · DOI · Paper page
- Kim, 2006, Structure and dynamics of PKA signaling proteins, Eur J Cell Biol, 85, 651, 10.1016/j.ejcb.2006.02.004 · doi:10.1016/j.ejcb.2006.02.004
- Kim, 2015, J Biol Chem, 290, 9604, 10.1074/jbc.M114.633198 · DOI
- Kim, 2013, cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes, EMBO J, 32, 1543, 10.1038/emboj.2013.102 · DOI · Paper page
- Kim, 2019, FusionGDB: fusion gene annotation DataBase, Nucleic Acids Res, 47, D994, 10.1093/nar/gky1067 · DOI
- Kirschner, 2000, Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex, Hum Mol Genet, 9, 3037, 10.1093/hmg/9.20.3037 · DOI · Paper page
- Knape, 2017, Divalent metal ions control activity and inhibition of protein kinases, Metallomics, 9, 1576, 10.1039/C7MT00204A · DOI
- Knighton, 1991, Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 407, 10.1126/science.1862342 · DOI · Paper page
- Knighton, 1991, Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 414, 10.1126/science.1862343 · DOI · Paper page
- Kolligs, 2002, Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis, Digestion, 66, 131, 10.1159/000066755 · DOI · Paper page
- Komatsu, 2014, A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes, PLoS One, 9, 10.1371/journal.pone.0087875 · DOI
- Kool, 2014, Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition, Cancer Cell, 25, 393, 10.1016/j.ccr.2014.02.004 · DOI · Paper page
- Lacka, 2015, Rare thyroid non-neoplastic diseases, Thyroid Res, 8, 5, 10.1186/s13044-015-0017-3 · DOI
- Landis, 1989, GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours, Nature, 340, 692, 10.1038/340692a0 · DOI · Paper page
- Langeberg, 2015, Signalling scaffolds and local organization of cellular behaviour, Nat Rev Mol Cell Biol, 16, 232, 10.1038/nrm3966 · DOI · Paper page
- Lania, 2006, Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases, Nat Clin Pract Endoc, 2, 681, 10.1038/ncpendmet0324 · DOI
- Lanzi, 1992, Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas, Oncogene, 7, 2189
- Larkin, 2014, Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas, Eur J Endocrinol, 171, 705, 10.1530/EJE-14-0545 · DOI
- Lavogina, 2010, Bisubstrate inhibitors of protein kinases: from principle to practical applications, ChemMedChem, 5, 23, 10.1002/cmdc.200900252 · DOI
200 of 392 shown
Cited by
Liquid–liquid phase separation drives cellular function and dysfunction in cancer
Mehta, S., & Zhang, J. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00444-7 · Cited by 437
Gritti, I., Wan, J., Weeresekara, V., Vaz, J. M., Tarantino, G., Bryde, T. H., Vijay, V., Kammula, A. V., Kattel, P., Zhu, S., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0634 · Cited by 20
Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A
Taylor, S. S., Herberg, F. W., Veglia, G., & Wu, J. (2023) · IUBMB Life · doi:10.1002/iub.2714 · Cited by 15
Self-citationOlivieri, C., Walker, C., Veliparambil Subrahmanian, M., Porcelli, F., Taylor, S. S., Bernlohr, D. A., & Veglia, G. (2023) · FEBS Letters · doi:10.1002/1873-3468.14610 · Cited by 10
Self-citationThe Intricate Relationship between Circadian Rhythms and Gastrointestinal Peptides in Obesity
Ribeiro, F. M., Arnaldo, L., P. Milhomem, L., S. Aguiar, S., & Franco, O. L. (2025) · Peptides · doi:10.1016/j.peptides.2025.171356 · Cited by 9
Metadata
- Authors
- Ramms, D. J., Raimondi, F., Arang, N., Herberg, F. W., Taylor, S. S., & Gutkind, J. S.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 73
- Issue
- 4
- Pages
- 1326-1368
- ISSN
- 0031-6997
- Cited by
- 82
- References
- 35
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling. https://app.cochat.ai/papers/10.1124/pharmrev.120.000269
- The paper
- Ramms, D. J., Raimondi, F., Arang, N., Herberg, F. W., Taylor, S. S., & Gutkind, J. S. (2021). Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling. Pharmacological Reviews. https://doi.org/10.1124/pharmrev.120.000269
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.